FindTrial
Sign In

Psychosocial support

BEHAVIORAL5 trials

Sponsors

Danish Cancer Society, Movember Foundation, Usona Institute, Universidad de La Frontera, Universitair Medisch Centrum Groningen

Conditions

Breast CancerDepressive Disorder, MajorHeart Failure NYHA Class IIHeart Failure NYHA Class IIIMetastatic Prostate Cancerpsychosociale problemen neuroendocrine tumor/distress quality of life

Phase 3

Psilocybin for Major Depressive Disorder (MDD)
Active, not recruitingNCT06308653
Usona InstituteDepressive Disorder, Major
Start: 2024-03-13End: 2026-12-30Target: 240Updated: 2025-12-15

Unknown Phase

Psychotherapy to Patients With Primary Breast Cancer - Psycho-social and Survival Outcome From a Randomised Trial
CompletedNCT01108224
Danish Cancer SocietyBreast Cancer
Start: 2004-01-31End: 2006-12-31Updated: 2010-04-21
Web-based tailored Information and support for patients with a Neuroendocrine tumor
Active, not recruitingNL-OMON41814
Universitair Medisch Centrum Groningenpsychosociale problemen neuroendocrine tumor/distress quality of life
Start: 2015-05-05Target: 90Updated: 2024-02-28
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
Active, not recruitingNCT02730338
Movember FoundationMetastatic Prostate Cancer
Start: 2016-01-31End: 2026-10-31Target: 866Updated: 2024-11-27
Comprehensive Hybrid Cardiac Rehabilitation Trial on Heart Failure
RecruitingNCT06313684
Universidad de La FronteraHeart Failure NYHA Class II, Heart Failure NYHA Class III
Start: 2024-04-01End: 2027-03-31Target: 152Updated: 2024-12-03

Related Papers

Meeting Aerobic Physical Activity Guidelines and Associations With Physical Fitness in Men With Metastatic Prostate Cancer: Baseline Results of the Multicentre <scp>INTERVAL</scp>‐<scp>GAP4</scp> Trial
Cancer Medicine2024-12-011 citations
CO-CREATION-HF protocol: clinical trial to evaluate the impact of a comprehensive and hybrid cardiac rehabilitation model on patients with heart failure
Frontiers in Cardiovascular Medicine2024-11-14
Enhancing circulatory myokines and extracellular vesicle uptake with targeted exercise in patients with prostate cancer (the MYEX trial): a single-group crossover study.
2024-07-01
Cardiopulmonary exercise testing of patients with metastatic castrate-resistant prostate cancer as screening for vigorous exercise medicine prescription.
JCO Global Oncology2023-08-01
Intense exercise for survival among men with metastatic prostate cancer: 12 months feasibility results from the INTERVAL-GAP4 trial.
JCO Global Oncology2023-08-01
Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol
BMJ Open2018-05-01136 citations